WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 6'155  6'103  6'041  5'964  5'877  5'176  4'260  3'078 
Births 130  131  132  132  131  116  122  129 
Surviving infants 128  129  130  130  129  113  118  121 
Pop. less than 5 years 645  646  644  641  637  548  601  565 
Pop. less than 15 years 1'811  1'796  1'779  1'766  1'753  1'723  1'785  1'419 
Female 15-49 years 1'739  1'721  1'700  1'674  1'644  1'359  924  617 

Number of reported case

(Click for retrospective incidence data for Libya)
Diphtheria
Japanese encephalitis
Measles 320  329  931  1'547 
Mumps 111  746  464 
Pertussis 197  16  22  43  25 
Polio* 30 
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 30 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Libya)
Vaccine year result method % card seen                                                
BCG 2006  100  FHS   81.0  100  100  100  90  88 
DTP1 2006  100  FHS   81.0  99  98  98 
DTP3 2006  98  FHS   81.0  98  98  98  84  60 
HepB_BD          100  100  100 
HepB3          98  98  98 
Hib3          98  98  98 
JapEnc         
MCV 2006  94  FHS   81.0  98  98  98  89  61 
MCV2          97  97  97 
PCV1         
PCV3         
Pol3 2006  98  FHS   81.0  98  98  98  84  60 
Rota1         
Rota_last         
Rubella1          98  98  98 
TT2plus          18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Libya)
BCG 99  99  99  99  99  98  90  88 
DTP1 99  99  98  98  98  97  94  82 
DTP3 98  98  98  98  98  94  84  60 
HepB3 98  98  98  98  98  92 
Hib3 98  98  98  98  98 
MCV 98  98  98  98  98  93  89  61 
PCV3
Pol3 98  98  98  98  98  94  84  60 
Rota_last

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 18 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HPV 15 years (x3); Yes for gilrs - from November 2013
HepB birth; Yes and not vaccinated adults
Influenza Yes High risk group and pilgrims
MMR 12, 18 months; Yes
MenACWY 6 years; Yes Travellers Hag and Omra
OPV birth; 2, 4, 6, 18 months; 6 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Pneumo_ps Yes adults - risk groups
Rotavirus 2, 4, 6 months; Yes From July 2013
TT Yes pregnant
Td 15 years;
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes      Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2008-2012      2008-2012  2008 - 2012  2005-2008  2005-2008 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes             

System performance

Total number of districts in country number 30      23  23  22  22 
Nº districts with DTP3 coverage >=80% number 30      23  23  22  22 
% of districts with DTP3 coverage >=80% From 0 to 100% 100      100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 17      16  10     
% of districts with MCV1 coverage >=95% From 0 to 100% 57      70  43     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No      No  No  No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes             

Finance

Percentage of routine vaccines funded by Government From 0 to 100%       100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.